Literature DB >> 2241113

Stroke in pediatric acquired immunodeficiency syndrome.

Y D Park1, A L Belman, T S Kim, K Kure, J F Llena, G Lantos, L Bernstein, D W Dickson.   

Abstract

In a 4 1/2-year period, 4 of 68 children in a longitudinal study of neurological complications of human immunodeficiency virus (HIV) infection had clinical and/or neuroradiological evidence of stroke, yielding a clinical incidence of stroke in this population of 1.3% per year. During this period, 32 subjects died, and permission for autopsy was granted in 18 of the patients, including 3 of 4 who had clinical evidence of stroke. The prevalence of cerebrovascular pathological features in our consecutive autopsy series was higher than the clinical incidence. At autopsy cerebrovascular disease was documented in 6 (24%) of 25 children with HIV infection, including all 3 children who had clinical evidence of stroke. Four patients had intracerebral hemorrhages, 6 patients had nonhemorrhagic infarcts, and 3 had both. Hemorrhage was catastrophic in 1 child and clinically silent in 3 children, all of whom had immune thrombocytopenia. One child had an arteriopathy that affected meningocerebral arteries. In another child, the arteries of the circle of Willis were aneurysmally dilated. Two children had coexisting cardiomyopathy and subacute necrotizing encephalomyelopathy with vascular proliferation. These results suggest that stroke should be considered when children with HIV infection develop focal neurological signs.

Entities:  

Mesh:

Year:  1990        PMID: 2241113     DOI: 10.1002/ana.410280302

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

Review 2.  Intracranial aneurysms: from vessel wall pathology to therapeutic approach.

Authors:  Timo Krings; Daniel M Mandell; Tim-Rasmus Kiehl; Sasikhan Geibprasert; Michael Tymianski; Hortensia Alvarez; Karel G terBrugge; Franz-Josef Hans
Journal:  Nat Rev Neurol       Date:  2011-09-20       Impact factor: 42.937

Review 3.  Hearing impairment after bacterial meningitis: a review.

Authors:  H M Fortnum
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

4.  Multifocal cerebral fusiform aneurysms in children with immune deficiencies report of four cases.

Authors:  J Sedat; H Alvarez; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

Review 5.  Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors:  C Exhenry; D Nadal
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

6.  Arterial dissection and subarachnoid haemorrhage in human immunodeficiency virus-infected patients. A report of three cases.

Authors:  A Taylor; D Lefeuvre; A Levy; S Candy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

7.  Angiocentric CD3(+) T-cell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children.

Authors:  C D Katsetos; J E Fincke; A Legido; H W Lischner; J P de Chadarevian; E M Kaye; C D Platsoucas; E L Oleszak
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

8.  Cerebral infarction in pediatric acquired immunodeficiency syndrome.

Authors:  D M Moriarty; J O Haller; J P Loh; S Fikrig
Journal:  Pediatr Radiol       Date:  1994

9.  Cerebrovascular Disease in Children Perinatally Infected With Human Immunodeficiency Virus in Zambia.

Authors:  Colleen L Schneider; Sarah Mohajeri-Moghaddam; Esau G Mbewe; Pelekelo P Kabundula; Owen Dean; Alexandra Buda; Michael J Potchen; Sylvia Mwanza-Kabaghe; Deanna Saylor; Heather R Adams; Gretchen L Birbeck; David R Bearden
Journal:  Pediatr Neurol       Date:  2020-08-05       Impact factor: 3.372

10.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.